Literature DB >> 11191359

Altered pulmonary vasoreactivity in the chronically hypoxic lung.

L A Shimoda1, J S Sham, J T Sylvester.   

Abstract

Prolonged exposure to alveolar hypoxia induces physiological changes in the pulmonary vasculature that result in the development of pulmonary hypertension. A hallmark of hypoxic pulmonary hypertension is an increase in vasomotor tone. In vivo, pulmonary arterial smooth muscle cell contraction is influenced by vasoconstrictor and vasodilator factors secreted from the endothelium, lung parenchyma and in the circulation. During chronic hypoxia, production of vasoconstrictors such as endothelin-1 and angiotensin II is enhanced locally in the lung, while synthesis of vasodilators may be reduced. Altered reactivity to these vasoactive agonists is another physiological consequence of chronic exposure to hypoxia. Enhanced contraction in response to endothelin-1 and angiotensin II, as well as depressed vasodilation in response to endothelium-derived vasodilators, has been documented in models of hypoxic pulmonary hypertension. Chronic hypoxia may also have direct effects on pulmonary vascular smooth muscle cells, modulating receptor population, ion channel activity or signal transduction pathways. Following prolonged hypoxic exposure, pulmonary vascular smooth muscle exhibits alterations in K+ current, membrane depolarization, elevation in resting cytosolic calcium and changes in signal transduction pathways. These changes in the electrophysiological parameters of pulmonary vascular smooth muscle cells are likely associated with an increase in basal tone. Thus, hypoxia-induced modifications in pulmonary arterial myocyte function, changes in synthesis of vasoactive factors and altered vasoresponsiveness to these agents may shift the environment in the lung to one of contraction instead of relaxation, resulting in increased pulmonary vascular resistance and elevated pulmonary arterial pressure.

Entities:  

Mesh:

Year:  2000        PMID: 11191359

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  37 in total

Review 1.  Hypoxia. 3. Hypoxia and neurotransmitter synthesis.

Authors:  Ganesh K Kumar
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-26       Impact factor: 4.249

Review 2.  Assessment of pulmonary hypertension by CT and MR imaging.

Authors:  Sebastian Ley; Karl-Friedrich Kreitner; Christian Fink; Claus P Heussel; Mathias M Borst; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2004-01-23       Impact factor: 5.315

3.  Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.

Authors:  Helen Christou; Ossama M Reslan; Virak Mam; Alain F Tanbe; Sally H Vitali; Marlin Touma; Elena Arons; S Alex Mitsialis; Stella Kourembanas; Raouf A Khalil
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

Review 4.  Store-operated calcium entry in vascular smooth muscle.

Authors:  F P Leung; L M Yung; X Yao; I Laher; Y Huang
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

5.  Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation.

Authors:  Krishna C Penumatsa; Deniz Toksoz; Rod R Warburton; Andrew J Hilmer; Tiegang Liu; Chaitan Khosla; Suzy A A Comhair; Barry L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-15       Impact factor: 5.464

6.  Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs.

Authors:  Jun Zhang; Wenju Lu; Yuqin Chen; Qian Jiang; Kai Yang; Meichan Li; Ziyi Wang; Xin Duan; Lei Xu; Haiyang Tang; Dejun Sun; Jian Wang
Journal:  Am J Physiol Cell Physiol       Date:  2016-07-13       Impact factor: 4.249

7.  Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.

Authors:  Mark E Orcholski; Ke Yuan; Charlotte Rajasingh; Halley Tsai; Elya A Shamskhou; Navneet K Dhillon; Norbert F Voelkel; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-08       Impact factor: 5.464

8.  Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.

Authors:  Helen Christou; Hannes Hudalla; Zoe Michael; Evgenia J Filatava; Jun Li; Minglin Zhu; Jose S Possomato-Vieira; Carlos Dias-Junior; Stella Kourembanas; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2017-12-06       Impact factor: 4.030

9.  Sodium tanshinone IIA sulfonate inhibits canonical transient receptor potential expression in pulmonary arterial smooth muscle from pulmonary hypertensive rats.

Authors:  Jian Wang; Qian Jiang; Limei Wan; Kai Yang; Yi Zhang; Yuqin Chen; Elizabeth Wang; Ning Lai; Lei Zhao; Hua Jiang; Yueqian Sun; Nanshan Zhong; Pixin Ran; Wenju Lu
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-11       Impact factor: 6.914

10.  Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells.

Authors:  Xinwen Wang; Hong Chai; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.